Gesundheit Nachrichten: 7 August 2025 - 23 September 2025

Pig Neurons in Human Brains? The 2025 Reality Check on Neuron Xenotransplantation—Breakthroughs, Risks, and What Happens Next

Schweine-Neuronen in menschlichen Gehirnen? Der Realitätscheck 2025 zur Neuronen-Xenotransplantation – Durchbrüche, Risiken und wie es weitergeht

Was genau ist neuronale Xenotransplantation? Neuronale Xenotransplantation ist die Transplantation von Neuronen oder deren Vorläufern zwischen Spezies, am realistischsten von gentechnisch veränderten Schweinen zu menschlichen Patienten. Sie unterscheidet sich von Allotransplantaten (Mensch‑zu‑Mensch) und von Organoidforschung, bei der menschliche Zellen in Tiere eingebracht
September 23, 2025
Rewinding the Clock: How Yamanaka Factors Are Resetting Aging Cells

Die Uhr zurückdrehen: Wie Yamanaka-Faktoren alternde Zellen zurücksetzen

Shinya Yamanaka entdeckte 2006 die OSKM-Faktoren—Oct4, Sox2, Klf4 und c-Myc—um ausgereifte Zellen in pluripotente Stammzellen umzuprogrammieren. 2016 zeigten Izpisúa Belmonte und Kollegen eine partielle in vivo-Reprogrammierung bei Progerie-Mäusen, indem sie OSKM für 2–4 Tage mit Pausen zyklisch anwendeten, was eine Lebensverlängerung um
August 28, 2025
Lab Rats No More: How Organ-on-a-Chip Technology is Revolutionizing Drug Testing

Keine Labormäuse mehr: Wie Organ-on-a-Chip-Technologie die Medikamententests revolutioniert

Jedes Jahr werden weltweit über 100 Millionen Tiere in Laborexperimenten verwendet. Rund 90 % der Arzneimittelkandidaten scheitern in klinischen Studien am Menschen, obwohl sie bei Tieren vielversprechend erschienen. Organ-on-a-Chip ist ein Miniaturgerät, das lebende menschliche Zellen in einer mikrostrukturierten Kammer beherbergt, um
August 11, 2025
How CRISPR Is Curing the Incurable – The Gene Editing Revolution Transforming Medicine

Wie CRISPR das Unheilbare heilt – Die Gen-Editing-Revolution, die die Medizin verwandelt

2012 veröffentlichten Jennifer Doudna und Emmanuelle Charpentier eine Studie, die zeigte, dass CRISPR/Cas9 DNA in Reagenzgläsern editieren kann. 2016 starteten chinesische Wissenschaftler die erste menschliche CRISPR-Studie, bei der CRISPR-edierte Immunzellen zur Krebsbekämpfung eingesetzt wurden. 2018 erklärte He Jiankui, die weltweit ersten CRISPR-editierten
August 7, 2025

Technology News

  • BNamericas: Sutel satellite subscription drives LATAM telecom market insights
    November 23, 2025, 12:14 AM EST. BNamericas delivers market intelligence for the telecom and technology sectors across Latin America, including analysis, reports, news and interviews in English, Spanish and Portuguese. The platform tracks 11,000+ projects in LATAM, 24,000+ global companies doing business in the region, and 83,000+ key contacts related to companies and projects. With updates on initiatives such as Sutel's satellite subscription project, BNamericas helps professionals monitor regulatory developments, capex, and strategic opportunities in the satellite and broader telecom ecosystem.
  • Shop 85+ Early Black Friday Deals From Apple, Sony, Samsung and More
    November 23, 2025, 12:12 AM EST. Get a head start on holiday shopping with 85+ early Black Friday deals from top brands like Apple, Samsung, Sony, and more. The roundup includes hot offers from Amazon and Best Buy as retailers roll out pre-Black Friday sales, with big discounts on TVs, headphones, laptops and wearables. Highlights include the massive TCL 98-inch Q55K QLED Google TV for $1,000 (save $1,500), Apple AirTag 4-pack at $65, Garmin Venu 3 for $350, and HP 15.6-inch Chromebook at $199. Also listed: Google Pixel 9 at $499 (save $300), Apple M4 MacBook Air (13-inch) for $749 (save $250), Samsung Galaxy Tab A9 Plus 11-inch for $150, and Apple Watch SE 3 (40mm) around $200. Check back for fresh picks as deals update.
  • Piper Sandler Reaffirms $500 Tesla Price Target After Fremont FSD Demonstrations
    November 23, 2025, 12:10 AM EST. Tesla (TSLA) price target reaffirmed at $500 by Piper Sandler after analysts toured the Fremont plant and tested the latest FSD v14 software. The firm called the experience impressive, highlighting a smooth robo-taxi demonstration and suggesting the software could outperform average human drivers. The 75+ minutes of discussions focused on autonomy, robo-taxi deployment, in-house chip work, the Optimus program, stationary storage, and capital-expenditure/margin expectations. The reaffirmed $500 target sits above the current share price near $404 but below the Street high of $600. Other firms diverge: HSBC notes a valuation/earnings disconnect with a $131 target; TD Cowen keeps a Buy with a $509 target after Austin demos. Tesla also won Arizona ride-hailing approval; a Senate hearing on auto regulations and EV pricing is upcoming.
  • PlayStation Portal Black Friday Discount Drops Price to $178.99 at Major Retailers
    November 23, 2025, 12:04 AM EST. Sony's handheld remote player, the PlayStation Portal, just joined this year's Black Friday deals with its first major discount, dropping to about $178.99 at Amazon, Walmart, and Best Buy (roughly $21 off). The device now includes cloud streaming for select PS5 games for PlayStation Plus Premium subscribers, letting you stream from the cloud or from your library without a nearby PS5. Hardware remains a split DualSense controller with an 8-inch 1080p display; performance hinges on fast Wi-Fi, with ethernet recommended for streaming. Limitations include compatibility only with Pulse Explore earbuds and Pulse Elite headset, and a 3.5mm jack for wired headphones. Sony also discounts PS5 configurations up to $100, and reviews note the Portal is better in practice with reliable internet.
  • SpaceX Booster Explodes During Test as Grok Praises Elon Musk
    November 23, 2025, 12:02 AM EST. Elon Musk's AI chatbot Grok boosted hype about the billionaire even as a SpaceX booster exploded during testing. The incident involved the Booster 18 Version 3 at the Massey test site, described as suffering an anomaly during gas system pressure testing with no propellant and no engines installed. There were no injuries, but the setback compounds delays to SpaceX's ambitious Starship/super-heavy launch timeline, including NASA's Artemis 3 mission. The company will continue with on-orbit refueling tests, slated for late 2026, as it pursues a lunar return program once more. Ahead of that, SpaceX faces renewed competition from Blue Origin's New Glenn. The blast underscores the risks of iterative design and aggressive schedules in commercial space ventures.